My clients typically win well before trial, but I love winning in the courtroom, too.
(District of Delaware) Represented Chugai in patent litigation involving Chugai’s revolutionary antibody recycling technology. The team secured a $775 million for Chugai hours before jury selection and opening statements at trial.
(District of Delaware) Representing Chugai Pharmaceuticals in litigation involving Chugai’s prescription hemophilia medicine, Hemlibra®. Helped devise strategy to defeat a preliminary injunction motion and to get Chugai dismissed from the case, which is currently on appeal.
(District of Delaware) Represented DNA Genotek in litigation asserting patent involving DNA sample collection devices. Obtained an eight–figure settlement and ongoing royalty following favorable IPR and claim construction proceedings.
(Eastern District of Texas) Represented Alcon and Sandoz at trial in Hatch–Waxman litigation involving glaucoma medication. Assumed case from prior counsel who lost first trial. Devised a new regulatory strategy that resulted in noninfringement verdict after convincing court to order a new trial.
(District of Delaware) Represented Dole in a patent infringement case involving RFID technology. Successfully argued motion to stay case pending reexamination before the PTO and then settled case on favorable terms.
(District of Delaware) Represented DexCom in a patent infringement case involving continuous blood glucose monitoring systems. Defeated preliminary injunction efforts, allowing client to become first to launch product.
(District of Delaware) Represented Maxwell in a case in which both parties asserted patents against each other. Obtained rare transfer out of the District of Delaware when both plaintiff and defendant were Delaware corporations. Maxwell ultimately obtained a preliminary injunction for infringement of its patents. Led appeal team to preserve the injunction, settling on favorable terms on the eve of the Federal Circuit argument.
(District of Delaware) Represented accused infringer and was part of the team that obtained a verdict of patent invalidity for obviousness. Argued and won appeal before U.S. Court of Appeals for the Federal Circuit.
Recognized for Litigation: Intellectual Property and Patent
Best Lawyers 2023-2024
Named Life Sciences Star in Patent Litigation
Legal Media Group 2022